Quirós, C, Granados, M, Picón, MJ, Nattero-Chávez, L, Aguilera, E, Vallejo, R, Beato-Víbora, PI, Azriel, S, Moreno-Fernandez, J, Simó-Servat, O, Arauco, RZ, Díaz-Soto, G, Alonso-Carril, N, Martínez-Brocca, MA, Díaz, O, Guerrero, L, Plata, PA, Durán, M, Márquez, R, León, MP, Climent, E, Fernández, KA, Ballesteros, AC. ADVANCED HYBRID CLOSED LOOP SYSTEM INITIATION SAFELY IMPROVES GLYCEMIC CONTROL IN OLDER ADULTS WITH TYPE 1 DIABETES. Diabetes Technology & Therapeutics. 2026; 28DOI:. PMID:. IF:6.300(Q1/2D).

Puig, R, Rodríguez-Peña, MM, Hernández-Montoliu, L, Astiarraga, B, Martínez, E, Balibrea, JM, Llauradó, G, Tarascó, J, Caballero, A, Joaquín, C, Puig-Domingo, M, Vilarrasa, N, Fernández-Veledo, S, Vendrell, J, Pellitero, S. Insulin resistance modulates gut microbiota and incretin response remodeling after bariatric surgery in severe obesity. INTERNATIONAL JOURNAL OF OBESITY. 2026; 50(3)DOI:10.1038/s41366-025-01971-7. PMID:41520055. IF:3.800(Q2/4D).

Gomez-Peralta, F, Corcoy, R, Santos, E, Borrachero, JM, Abreu, C, Valledor, X, Pérez-González, J, Ruiz-Valdepeñas, L. IMPROVEMENT IN INSULIN INJECTION TIMING AND GLYCEMIC CONTROL USING A CONNECTED INSULIN CAP: THE INSULCLOCK V2.0 PROSPECTIVE STUDY. Diabetes Technology & Therapeutics. 2026; 28DOI:. PMID:. IF:6.300(Q1/2D).

Bailey, T, Davies, M, Hao, LC, Ji, L, Mk, L, Mabunay, MA, Mauricio, D, Ritzel, R. INTENSIFICATION WITH INSULIN GLARGINE 300 U/ML (GLA-300) IN PEOPLE WITH TYPE 2 DIABETES (PWT2D) RECEIVING TIRZEPATIDE THERAPY: DELIVER-. Diabetes Technology & Therapeutics. 2026; 28DOI:. PMID:. IF:6.300(Q1/2D).